BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2025 10:46:29 AM | Browse: 55 | Download: 75
 |
Received |
|
2024-11-28 10:14 |
|
Peer-Review Started |
|
2024-12-03 00:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-01-08 06:20 |
|
Revised |
|
2025-01-16 15:48 |
|
Second Decision |
|
2025-01-22 02:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-01-22 07:00 |
|
Articles in Press |
|
2025-01-22 07:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-02-03 12:05 |
|
Publish the Manuscript Online |
|
2025-02-28 10:46 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Comprehensive impact of PPARG mutations in familial partial lipodystrophy type 3: Diagnosis, therapeutic strategies
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Heng-Li Lai and Liu Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Liu Yang, MD, PhD, Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, No. 152 Aiguo Avenue, Nanchang 330006, Jiangxi Province, China. ciwujia@foxmail.com |
| Key Words |
Familial partial lipodystrophy type 3; Genetic testing; Metabolic disorders; Personalized treatment |
| Core Tip |
The exploration of PPARG mutations, such as the Y151C variant, reveals the genetic basis of familial partial lipodystrophy type 3 (FPLD3) and its related metabolic syndromes. This commentary emphasizes the importance of genetic testing for precise diagnosis and treatment while advocating for further research into clinical phenotype variability and targeted therapies. Advancing personalized medicine and deepening our understanding of PPARG-related pathways can significantly improve clinical outcomes for FPLD3 patients. |
| Publish Date |
2025-02-28 10:46 |
| Citation |
<p>Lai HL, Yang L. Comprehensive impact of PPARG mutations in familial partial lipodystrophy type 3: Diagnosis, therapeutic strategies. <i>World J Diabetes</i> 2025; 16(4): 103675</p> |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i4/103675.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i4.103675 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
